US Stocks
/
Japer Therapeutics, Inc. Warrants Share Price
Japer Therapeutics, Inc. Warrants Share Price

Japer Therapeutics, Inc. Warrants Share Price

NASDAQ: JSPRW
$0.00
+0.00 (0.00%)
  • Performance
  • Chart
  • Fundamentals
  • Quarterly P&L
  • Annual P&L
  • About
  • Price history
  • FAQs

Japer Therapeutics, Inc. Warrants Stock Performance

Open
N/A
Prev. Close
N/A
Circuit Range
N/A
Day Range
N/A
Year Range
N/A
Volume
N/A
Average Traded
N/A

Japer Therapeutics, Inc. Warrants Share Price Chart

$0.00$0.00
L
Show Current Price
H

Japer Therapeutics, Inc. Warrants Stock Fundamentals & Key Indicators

Market Cap
N/A
PE Ratio (TTM)
N/A
Dividend Yield
N/A
EPS (TTM)
N/A
Revenue (TTM)
$0.00
Return On Equity (TTM)
-2248.48%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
85.27%

Japer Therapeutics, Inc. Warrants Quarterly Profit & Loss

All figures in USD

ParticularsSep 2025Dec 2025Mar 2026Jun 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$18.74-$9.10-$1.17-$2.76
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A51.44%87.14%-135.90%

Japer Therapeutics, Inc. Warrants Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$37.69-$64.47-$71.27-$75.80
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-71.05%-10.55%-6.36%

About Japer Therapeutics, Inc. Warrants

Jasper Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics targeting mast cell driven diseases such as Chronic Spontaneous Urticaria (CSU), Chronic Inducible Urticaria (CIndU) and asthma. The company's lead product candidate, briquilimab, is a monoclonal antibody designed to block stem cell factor (SCF) from binding to and signaling through the CD117 (KIT) receptor on mast and stem cells. The company has a single operating and reportable segment, which is the research and development of therapeutic products in the fields of chronic urticaria and asthma.

Japer Therapeutics, Inc. Warrants Historical Returns

MonthOpenCloseChange %

JSPRW Share Price FAQs

What is Japer Therapeutics, Inc. Warrants share price today?

chevron-up
Japer Therapeutics, Inc. Warrants share price today is $0.00 as on October 9, 2026 at 4:46 pm IST.

What is the 52 week high and 52 week low of Japer Therapeutics, Inc. Warrants stock?

chevron-up
52 week high/low data for Japer Therapeutics, Inc. Warrants is currently unavailable.

What is JSPRW's net income for the last quarter?

chevron-up
JSPRW's net income for the last quarter is -2.76B USD.

Can I buy JSPRW shares in India?

chevron-up
Yes. You can buy JSPRW in India by opening an international trading account.